Thursday, March 5, 2009

Celiac Disease Versus Gluten Sensitivity: New Role for Genetic Testing and Fecal Antibody Testing?

 


<p>Celiac disease (CD) has a prevalence of 1/100. Between 90-99% of Celiacs are HLA  DQ2 and/or DQ8 positive. Every individual has two DQ serotypes. Because the  molecular HLA nomenclature can be confusing DQ serotyping is a method for  simplifying the results. There are four major types and 5 subtypes: HLA DQ1, DQ2,  DQ3 and DQ4; DQ1 has two subtypes; DQ5 and DQ6 whereas DQ3 has three  subtypes; DQ7, DQ8 and DQ9. Each individual has two copies of HLA DQ. One DQ  type is inherited from each parent.</p><p>Though 35-45% of individuals of Northern European ancestry are DQ2 &/or DQ8  positive only 1% have classic CD as defined by abnormal blood tests and small  intestine biopsies. Several autoimmune conditions also occur more frequently in  DQ2 and DQ8 positive individuals.</p><p>There is accumulating scientific evidence that many individuals are gluten sensitive  and respond to a gluten free diet though they have normal blood tests and/or  normal intestinal biopsies (fail to meet strict criteria for CD). This is more commonly  being referred to as non-Celiac gluten sensitivity (NCGS).  Many individuals who  have NCGS are relatives of confirmed Celiacs and were previously referred to as  latent Celiacs.  Electron microscopy and immunohistochemistry studies of  individuals with normal biopsies but suspected of or at risk (1st degree relatives of  Celiacs) have revealed ultrastructural abnormalities of the intestine and those who  chose a gluten free diet usually responded and many who did not ultimately  developed abnormal biopsies on long term follow-up.  Seronegative Celiac has also  been recognized, that is blood tests are negative, but the biopsy reveals classic  abnormalities of Celiac and the individual responds to gluten free diet.</p><p>Fecal antibody testing for gliadin (AG) and tissue transglutaminase (tTG) by  Enterolab in Dallas has revealed elevations in 100% of Celiacs tested and up to 60%  of symptomatic individuals without Celiac disease (NCGS) even if not DQ2 or DQ8  positive.The only DQ pattern he  found not associated with gluten sensitivity is DQ4/DQ4, a pattern typically found in  non-Caucasians who are known to have a low prevalence of Celiac disease.</p><p>Testing for DQ2/DQ8 has been suggested as a way to exclude CD. That is, if you are  negative for DQ2 and DQ8, then you are very unlikely to have CD.  However, well  documented cases of CD and Dermatitis Herpetiformis (DH) have been confirmed in  DQ2 and DQ8 negative individuals. Moreover, we now have the clinical experience  that other DQ patterns predispose a person to gluten sensitivity because these individuals  frequently have elevated fecal antibodies to AG or tTG and respond to a gluten free  diet.</p><p>Why some people develop Celiac Disease or become gluten sensitive is not well  understood.  Risk factors include onset of puberty, pregnancy, stress, trauma or  injury, surgery, viral or bacterial infections including those of the gut, medication  induced gut injury or toxicity (e.g. NSAIDs), immune suppression or autoimmune  diseases, and antibiotic use resulting in altered gut flora (dysbiosis).  The severity of  the sensitivity is related to the DQ type, pre-existing intestinal injury, degree of  exposure to gluten (how frequent and large a gluten load an individual is exposed  to), and immune status.  Once initiated, gluten sensitivity tends to be lifelong.  True CD  requires lifelong complete gluten avoidance to prevent serious complications,  cancers, and early death.</p><p>Serotypes can be determined from blood or buccal mucosal cells (obtained by oral  swab) from several commercial labs including Prometheus, Labcorp, Quest, The  Laboratories at Bonfils, and Enterolabs. Fecal IgA anti-gliadin and IgA tissue  transglutaminase antibody testing is only available in the U.S. commercially through  Enterolabs. The fecal AG and tTG testing may be helpful in those with normal blood  tests for Celiac and/or a normal small bowel biopsy but suspected of being gluten  sensitive. Though the fecal antibody results are not widely accepted by many "Celiac  experts" numerous testimonials of individuals testing positive only on fecal tests  who have responded to gluten free diet can be found in support groups, web  postings, personal communication from Dr. Fine and this physician's clinical  experience.</p><p>Bibliography</p><p>Abrams et.al. Seronegative celiac disease:increased prevalence with lesser degrees  of villous atrophy. Dig Dis Sci 2004;49:546-550.</p><p>Alaedini A. and Green P.H.R. Narrative Review: Celiac Disease: Understanding a  Complex Autoimmune Disorder. Ann Intern Med. 2005;142:289-298.</p><p>Arranz et. al. Jejunal fluid antibodies and mucosal gamma/delta IEL in latent and  potential coeliac disease. Adv Exp Med Biol. 1995; 371B:1345-1348.</p><p>Dewar D. and Ciclitira P. Clinical Features and Diagnosis of Celiac Disease.  Gastroenterology 2005;128:S19</p><p>Kappler et.al. Detection of secretory IgA antibodies against gliadin and human  tissue transglutaminase in stool to screen for coeliac disease in children:validation  study. BMJ 2006; 332:213-214</p><p>Kaukinen et.al. HLA-DQ Typing in the Diagnosis of Celiac Disease. Am J  Gastroenterol. 2002;97(3):695-699.</p><p>Fine KD and Rostami K. Don’t throw the baby out with the bath water. BMJ February  13, 2006 rapid response editorial</p><

No comments: